Floatz logo

Therapeutic Asset Ratings

383 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Sargramostim
Glioblastoma
Children's Oncology GroupP2CCC (55)
Survaxm
Glioblastoma
Children's Oncology GroupP2CCC (55)
Bortezomib
T-Lymphoblastic Lymphoma
Children's Oncology GroupP2/3CCC (55)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
T-Lymphoblastic Lymphoma
Children's Oncology GroupP2/3CCC (55)
CIS-DIAMMINEDICHLOROPLATINUM II
Stage II T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
DARATUMUMAB
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
FILGRASTIM
Stage II T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
PEGASPARGASE
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Solu-Cortef
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Solu-Cortef
T-Lymphoblastic Lymphoma
Children's Oncology GroupP2/3CCC (55)
THIOGUANINE ANHYDROUS
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
aciclovir
Cancer
Children's Oncology GroupP3CCC (54)
Dexrazoxane
B-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3CCC (54)
Dexrazoxane
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Dexrazoxane
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3CCC (54)
Ifosfamide
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Ifosfamide
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3CCC (54)
Imatinib
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Inotuzumab Ozogamicin
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Levoleucovorin
Mixed Phenotype Acute Leukemia
Children's Oncology GroupP3CCC (54)
Levoleucovorin
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3CCC (54)
Montanide Isa 51
Glioblastoma
Children's Oncology GroupP2CCC (54)
Calaspargase Pegol
Acute Myeloid Leukemia, MLL Gene Rearrangement
Children's Oncology GroupP2CCC (53)
Calaspargase Pegol
Recurrent B Lymphoblastic Lymphoma
Children's Oncology GroupP2CCC (53)
Showing 251 to 275 of 383 assets
PreviousPage 11 of 16Next